Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Statistical quality control in clinical trials.

G Svolba1, P Bauer

  • 1University of Vienna, Austria.

Controlled Clinical Trials
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Torque regulation is affected by joint angle during isometric contraction in young male adults.

Scientific reports·2026
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson in the bb[over ¯] Final State Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same journal

On the generation and ownership of alpha in medical studies.

Controlled clinical trials·2004
Same journal

An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

Controlled clinical trials·2004
Same journal

Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

Controlled clinical trials·2004
Same journal

Statistical comparison of random allocation methods in cancer clinical trials.

Controlled clinical trials·2004
Same journal

Analyzing bronchodilation with emphasis on disease type, age and sex.

Controlled clinical trials·2004
Same journal

Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

Controlled clinical trials·2004
See all related articles

Statistical process control methods enhance clinical trial monitoring by analyzing patient data over time. These quality control tools improve data accuracy and trial management efficiency.

Area of Science:

  • Clinical trial methodology
  • Statistical quality control
  • Biostatistics

Background:

  • Clinical trials generate vast amounts of data requiring robust monitoring.
  • Traditional monitoring methods may not fully leverage accumulating data for real-time insights.
  • Industrial process control offers proven statistical tools for quality assurance.

Purpose of the Study:

  • To adapt and apply industrial process and quality control statistical methods to clinical trial data.
  • To address challenges in applying these methods to time-dependent patient and monitoring characteristics.
  • To demonstrate the utility of these methods in enhancing clinical trial oversight.

Main Methods:

  • Application of Shewhart charts, breakpoint regression, and recursive residuals.

Related Experiment Videos

  • Utilizing cumulative sum (cusums) and V-charts for monitoring.
  • Analysis of both measurement and event data within a clinical trial context.
  • Development of SAS macros for practical implementation.
  • Main Results:

    • Demonstrated successful application of statistical process control tools to clinical trial data.
    • Graphical examples from a primary malignant melanoma trial illustrate method effectiveness.
    • The proposed methods provide a framework for enhanced data monitoring over calendar and patient time.

    Conclusions:

    • Statistical methods from industrial quality control can significantly enhance clinical trial monitoring.
    • These methods offer valuable tools for real-time data analysis and quality assurance in trials.
    • The SAS-based software facilitates the practical application of these advanced monitoring techniques.